This hypothesis is in good agreement with our data indicating that Endocan has a similar but not identical effect as PDGF-BB– one of the cognate ligands of PDGFRA, suggesting that Endocan may activate other yet unknown receptors in GBM. Here, PDGFRA is linked to glioblastoma.